The Hippo in the room: Targeting the Hippo signalling pathway for osteosarcoma therapies.

Journal of Cellular Physiology
Emel RothzergJiake Xu

Abstract

Osteosarcoma (OS) is a primary malignant bone tumour which usually occurs in children and adolescents. OS is primarily a result of chromosomal aberrations, a combination of acquired genetic changes and, hereditary, resulting in the dysregulation of cellular functions. The Hippo signalling pathway regulates cell and tissue growth by modulating cell proliferation, differentiation, and migration in developing organs. Mammalian STE20-like 1/2 (MST1/2) protein kinases are activated by neurofibromatosis type 2, Ras association domain family member 2, kidney and brain protein, or other factors. Interactions between MST1/2 and salvador family WW domain-containing protein 1 activate large tumour suppressor kinase 1/2 proteins, which in turn phosphorylate the downstream Yes-associated protein 1/transcriptional coactivator with PDZ-binding motif (YAP/TAZ). Moreover, dysregulation of this pathway can lead to aberrant cell growth, resulting in tumorigenesis. Interestingly, small molecules targeting the Hippo signalling pathways, through affecting YAP/TAZ cellular localisation and their interaction with members of the TEA/ATTS domain family of transcriptional enhancers are being developed and hold promise for the treatment of OS. This review...Continue Reading

References

Jun 1, 2010·Cell Communication and Signaling : CCS·Ho-Jin Lee, Jie J Zheng
Oct 19, 2010·Developmental Cell·Duojia Pan
Jun 17, 2011·Cell Death & Disease·Z Salah, R I Aqeilan
Jan 21, 2012·Biochemical Society Transactions·Alexander Hergovich
Nov 16, 2012·Tissue Engineering. Part B, Reviews·Tong Ming Liu, Eng Hin Lee
Sep 12, 2013·Science Signaling·Gongping Sun, Kenneth D Irvine
Sep 21, 2013·Trends in Pharmacological Sciences·Hyun Woo Park, Kun-Liang Guan
Nov 29, 2013·Biopharmaceutics & Drug Disposition·Min-Koo ChoiIm-Sook Song
May 16, 2014·EMBO Reports·Jung-Soon MoKun-Liang Guan
Jun 14, 2014·Advances in Experimental Medicine and Biology·Jared R MortusDennis P M Hughes
Nov 12, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zheng ZhouNing Qin
Feb 6, 2015·International Journal of Oncology·Liwen Guo, Lisong Teng
Feb 14, 2015·Genes & Diseases·Zhongliang WangTong-Chuan He
Mar 5, 2015·Anti-cancer Agents in Medicinal Chemistry·Na LiQiping Zheng
Apr 4, 2015·Nature Communications·Upal Basu-RoyClaudio Basilico
Sep 22, 2015·Frontiers in Oncology·Michael D DeelCorinne M Linardic
May 22, 2016·Chinese Journal of Cancer·Dong-Yu WangWen-Zhi Bi
Aug 6, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Linda Truebestein, Thomas A Leonard
Nov 5, 2016·Journal of Cellular Biochemistry·Nimmish Khera, Sandeep Rajput
Jan 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·S Rubina BaglioD Michiel Pegtel
Jan 6, 2017·Cell Death & Disease·Jianjun MaShunwu Fan
May 10, 2017·Biochemical and Biophysical Research Communications·Jiwei ChaiFengbo Guo
Jun 16, 2017·Molecular & Cellular Oncology·Atif A AhmedEugenio Taboada
Sep 23, 2018·Oncogenesis·Yvonne de JongJudith V M G Bovée
Nov 8, 2018·Cancers·Liqing Wu, Xiaolong Yang

❮ Previous
Next ❯

Citations

Aug 28, 2021·Genes·Emel RothzergSulev Kõks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

Clinical and Translational Medicine
Marta GomezAlexander Hergovich
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
A L ZygulskaP Pierzchalski
Cells
Konstantin MasliantsevPierre-Olivier Guichet
© 2021 Meta ULC. All rights reserved